PATRICIA TURNBOW: Open Payments
NPI 1083852412 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,125 in 54 payments from 19 companies in 2025. Trend: 2023 $16 · 2024 $71 · 2025 $1,125
Food & beverage: $1,125
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $164 |
| GlaxoSmithKline, LLC. | 13 | $142 |
| ABBVIE INC. | 8 | $141 |
| Phathom Pharmaceuticals, Inc. | 3 | $138 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $97 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| Lilly USA, LLC | 4 | $70 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| PFIZER INC. | 2 | $31 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $27 |
Products named: Wegovy, VOQUEZNA, Kerendia, TRELEGY ELLIPTA, MOUNJARO, REXULTI, QULIPTA, VRAYLAR.
Industry payments across TX — which companies pay providers there.
